Biotech Course Correction With Treehill Partners' Ali Pashazadeh

Business Of Biotech

We love to hear from our listeners. Send us a message.

It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets. In fact, he still wields a scalpel quite frequently, and on this episode of the Business of Biotech podcast, he offers a fantastic reason why. Yes, it's a bit of a departure from our normal routine of biotech founders occupying the guest chair. But, Pashazadeh's no-holds-barred reflections on and analysis of biotech breaking points, drawn from more than 2 decades of troubleshooting broken bipharmaceutical businesses and correcting courses, makes for some great programming. Whether you're a biotech builder in the throes of disruption, or feeling lucky that you've been threading scientific, clinical, capital, and regulatory needles all along, this episode offers a ton of insight from the unwritten textbooks on the business of biotech.

Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.

Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: [email protected]
Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

Chapters

1. Biotech Course Correction With Treehill Partners' Ali Pashazadeh (00:00:00)

2. Ali Ashazadeh (00:00:04)

3. Medical Doctor Turned Investment Banker (00:14:19)

4. Improving Drug Development Decision-Making (00:26:02)

5. Optimizing Drug Development Decision-Making (00:35:38)

6. Navigating External Influences in Biotech (00:46:01)

7. Navigating Emotional Challenges in Biotech (01:01:07)

8. The Importance of Clinical Trial Disclosure (01:10:35)